Skip to main content
Immunology logoLink to Immunology
. 1982 Jun;46(2):253–260.

Immunoreactivity of long lived H-2 incompatible irradiation chimeras (H-2d leads to H-2b).

G J Maestroni, W Pierpaoli, R M Zinkernagel
PMCID: PMC1555366  PMID: 6211405

Abstract

Allogenic irradiations bone marrow chimeras made according to a new protocol with unmanipulated bone marrow are long lived, healthy and stable full chimeras (H-2d leads to H-2b). Their immunocompetence is split. Alloreactivity measured by skin graft rejection and mixed lymphocyte culture is within normal range. In contrast, major histocompatibility complex (MHC)-restricted T-cell-dependent primary responses against sheep red blood cells (SRBC) or viruses are clearly deficient. The quantitative difference in immunocompetence is at least of the order of ten-to thirty-fold. The implications of the findings for lymphohaemopoietic reconstitution of immunodeficient patients are briefly discussed.

Full text

PDF
253

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bevan M. J. Killer cells reactive to altered-self antigens can also be alloreactive. Proc Natl Acad Sci U S A. 1977 May;74(5):2094–2098. doi: 10.1073/pnas.74.5.2094. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Blume K. G., Beutler E., Bross K. J., Chillar R. K., Ellington O. B., Fahey J. L., Farbstein M. J., Forman S. J., Schmidt G. M., Scott E. P. Bone-marrow ablation and allogeneic marrow transplantation in acute leukemia. N Engl J Med. 1980 May 8;302(19):1041–1046. doi: 10.1056/NEJM198005083021901. [DOI] [PubMed] [Google Scholar]
  3. Bortin M. M., Rimm A. A. Severe combined immunodeficiency disease. Characterization of the disease and results of transplantation. JAMA. 1977 Aug 15;238(7):591–600. [PubMed] [Google Scholar]
  4. Dauphinee M. J., Nordin A. A. Studies of the immunological capacity of germ-free mouse radiation chimeras. IV. Cell-mediated immunity. Cell Immunol. 1974 Dec;14(3):394–401. doi: 10.1016/0008-8749(74)90189-0. [DOI] [PubMed] [Google Scholar]
  5. Finberg R., Burakoff S. J., Cantor H., Benacerraf B. Biological significance of alloreactivity: T cells stimulated by Sendai virus-coated syngeneic cells specifically lyse allogeneic target cells. Proc Natl Acad Sci U S A. 1978 Oct;75(10):5145–5149. doi: 10.1073/pnas.75.10.5145. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Krown S. E., Coico R., Scheid M. P., Fernandes G., Good R. A. Immune function in fully allogeneic mouse bone marrow chimeras. Clin Immunol Immunopathol. 1981 May;19(2):268–283. doi: 10.1016/0090-1229(81)90069-6. [DOI] [PubMed] [Google Scholar]
  7. Lafferty K., Ryan M., Misko I. An improved system for the assay of stimulation in mouse mixed leucocyte cultures. J Immunol Methods. 1974 Mar;4(2):263–273. doi: 10.1016/0022-1759(74)90069-6. [DOI] [PubMed] [Google Scholar]
  8. Maestroni G. J., Pierpaoli W. Factor(s) elaborated by bone marrow that promote persistent engraftment of xenogeneic and semiallogeneic marrow. J Clin Lab Immunol. 1980 Nov;4(3):189–193. [PubMed] [Google Scholar]
  9. Onoé K., Yasumizu R., Oh-Ishi T., Kakinuma M., Good R. A., Morikawa K. Restricted antibody formation to sheep erythrocytes of allogeneic bone marrow chimeras histoincompatible at the K end of the H-2 complex. J Exp Med. 1981 Apr 1;153(4):1009–1014. doi: 10.1084/jem.153.4.1009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Pierpaoli W., Maestroni G. J., Sache E. Enduring allogeneic marrow engraftment via nonspecific bone-marrow-derived regulating factors (MRF). Cell Immunol. 1981 Jan 1;57(1):219–228. doi: 10.1016/0008-8749(81)90134-9. [DOI] [PubMed] [Google Scholar]
  11. Pierpaoli W., Maestroni G. J. The facilitation of enduring engraftment of allogeneic bone marrow and avoidance of secondary disease in mice. Cell Immunol. 1980 Jun;52(1):62–72. doi: 10.1016/0008-8749(80)90400-1. [DOI] [PubMed] [Google Scholar]
  12. Slavin S., Strober S., Fuks Z., Kaplan H. S. Induction of specific tissue transplantation tolerance using fractionated total lymphoid irradiation in adult mice: long-term survival of allogeneic bone marrow and skin grafts. J Exp Med. 1977 Jul 1;146(1):34–48. doi: 10.1084/jem.146.1.34. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Smith F. I., Miller J. F. Suppression of T cells specific for the nonthymic parental H-2 haplotype in thymus-grafted chimeras. J Exp Med. 1980 Jan 1;151(1):246–251. doi: 10.1084/jem.151.1.246. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Storb R., Weiden P. L., Prentice R., Buckner C. D., Clift R. A., Einstein A. B., Fefer A., Johnson F. L., Lerner K. G., Neiman P. E. Aplastic anemia (AA) treated by allogeneic marrow transplantation: the Seattle experience. Transplant Proc. 1977 Mar;9(1):181–185. [PubMed] [Google Scholar]
  15. Tosolini F. A., Mims C. A. Effect of murine strain and viral strain on the pathogenesis of lymphocytic choriomeningitis infection and a study of footpad responses. J Infect Dis. 1971 Feb;123(2):134–144. doi: 10.1093/infdis/123.2.134. [DOI] [PubMed] [Google Scholar]
  16. Urso P., Gengozian N. T cell deficiency in mouse allogeneic radiation chimeras. J Immunol. 1973 Sep;111(3):712–719. [PubMed] [Google Scholar]
  17. Zinkernagel R. M., Althage A., Callahan G., Welsh R. M., Jr On the immunocompetence of H-2 incompatible irradiation bone marrow chimeras. J Immunol. 1980 May;124(5):2356–2365. [PubMed] [Google Scholar]
  18. Zinkernagel R. M., Doherty P. C. MHC-restricted cytotoxic T cells: studies on the biological role of polymorphic major transplantation antigens determining T-cell restriction-specificity, function, and responsiveness. Adv Immunol. 1979;27:51–177. doi: 10.1016/s0065-2776(08)60262-x. [DOI] [PubMed] [Google Scholar]
  19. van Bekkum D. W. The double barrier in bone marrow transplantation. Semin Hematol. 1974 Jul;11(3):325–340. [PubMed] [Google Scholar]

Articles from Immunology are provided here courtesy of British Society for Immunology

RESOURCES